Haemophilus influenzae type B vaccine |
|
II |
DEC / 98 |
Halofantrine or its salts |
|
I |
DEC / 13 |
Halofuginone or its salts |
For veterinary use.
|
I |
MAY / 18 |
Haloperidol |
|
I |
DEC / 13 |
Haloprogin |
|
III |
SEP / 98 |
Halothane |
|
I |
DEC / 13 |
Hemin |
|
I |
AUG / 18 |
Heparin and its salts. |
except for topical use |
II |
SEP / 99 |
Hepatitis A vaccine |
|
I |
FEB / 02 |
Hepatitis B Adult vaccine |
|
I |
FEB / 02 |
Hepatitis B Pediatric vaccine |
|
II |
DEC / 98 |
Hepatitis B immune globulin |
|
I |
FEB / 02 |
Hetacillin or its salts or derivatives |
For veterinary use.
|
I |
DEC / 13 |
Hetastarch or its derivatives |
|
I |
DEC / 13 |
Hexachlorophene or its salts |
|
I |
DEC / 13 |
Hexacyclonate sodium |
|
I |
DEC / 13 |
Hexamethonium or its salts |
|
I |
DEC / 13 |
Histamine and its salts |
except for topical use |
II |
SEP / 98 |
Histrelin or its salts |
|
I |
DEC / 13 |
Homatropine and its salts |
for oral use in concentrations of 2 mg or less per dosage unit |
II |
SEP / 98 |
Homatropine and its salts |
for ophthalmic or parenteral use or in preparations for oral use containing more than 2 mg per dosage unit |
I |
SEP / 98 |
Human insulin |
|
II |
SEP / 98 |
Hyaluronic acid and its salts |
preparations in concentrations of 5% or more |
II |
SEP / 98 |
Hyaluronic acid or its salts |
For veterinary use - when sold or recommended for administration by intra-articular injection to horses.
|
I |
DEC / 13 |
Hyaluronidase |
|
II |
SEP / 98 |
Hydralazine or its salts |
|
I |
DEC / 13 |
Hydrocortisone aceponate |
For veterinary use.
|
I |
DEC / 13 |
Hydrocortisone or hydrocortisone acetate |
When sold in a concentration that provides 1% or less hydrocortisone in preparations for topical use on the skin in children under 2 years of age.
|
I |
DEC / 14 |
Hydrocortisone or hydrocortisone acetate. |
When sold in a concentration that provides 1% or less hydrocortisone in preparations for topical use on the skin in adults and children 2 years of age and over in package sizes containing more than 30 g.
|
I |
DEC / 14 |
Hydroquinone or its derivatives |
When sold in a concentration less than or equal to 2% in preparations for topical use on the skin
|
II |
JUN / 19 |
Hydroquinone or its derivatives |
When sold in a concentration greater than 2% in preparations for topical use on the skin.
|
I |
JUN / 19 |
Hydroxocobalamin or its salts |
When recommended as an antidote for cyanide poisoning.
|
I |
DEC / 13 |
Hydroxychloroquine or its salts |
|
I |
DEC / 13 |
4- Hydroxycoumarin or its derivatives |
Including but not limited to acenocoumarol when sold or recommended as anticoagulants.
|
I |
DEC / 13 |
Hydroxyephedrine and its salts |
|
II |
SEP / 98 |
Hydroxyurea |
|
I |
DEC / 13 |
Hydroxyzine or its salts or derivatives |
Including but not limited to cetirizine and hydroxyzine hydrochloride. cetirizine or its salts when sold in concentration greater than 8.5 milligrams cetirizine per unit dose.
|
I |
DEC / 13 |
Hyoscine and its salts and derivatives [scopolamine] |
except Hyoscine butylbromide, when recommended for parenteral use |
II |
AUG / 16 |
Hyoscine butylbromide |
When recommended for parenteral use.
|
I |
AUG / 16 |
Hyoscyamine and its salts and derivatives |
except for topical use |
II |
SEP / 98 |